Clinical Trial

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Study acronym: ARTIZEN
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Protocol Amendment History 2 changes
notable Trial sites expanded: 16 -> 19 locations 2026-05-23
notable Trial sites expanded: 10 -> 16 locations 2026-04-22
Trial Details
NCT Number NCT07089576
Lead Sponsor Artivion Inc.
Collaborators: Bright Research Partners
Conditions Aortic Arch Aneurysm, Aortic Arch Dissection, Chronic Aortic Dissection, Acute Aortic Dissection
Enrollment 132 participants
Start Date 2025-11-04
Primary Completion 2028-04 (estimated)
Study Completion 2032-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-10